Characteristic
|
All patients (n = 57)
|
Definitive treatment not delayed (n = 36)
|
Definitive treatment delayed (n = 21)
|
p value
|
---|
Age, mean (SD)
|
57.0 (21.9)
|
55.5 (21.5)
|
59.4 (22.8)
|
0.52a
|
Age group, n (%)
| | | |
0.36b
|
< 18 yrs
|
4 (7)
|
2 (6)
|
2 (10)
| |
18–65 yrs
|
29 (51)
|
21 (58)
|
8 (38)
| |
> 65 yrs
|
24 (42)
|
13 (36)
|
11 (52)
| |
Gender (male), n (%)
|
30 (53)
|
18 (50)
|
12 (57)
|
0.78c
|
ASA classification, n (%)
| | | |
0.89b
|
ASA I
|
15 (26)
|
10 (28)
|
5 (24)
| |
ASA II
|
18 (32)
|
10 (28)
|
8 (38)
| |
ASA III
|
23 (40)
|
15 (42)
|
8 (38)
| |
ASA IV
|
1 (2)
|
1 (3)
|
0
| |
Patient classification, n (%)
| | | |
0.016c
|
Internal medicine
|
20 (35)
|
10 (28)
|
10 (48)
| |
Neurology
|
22 (39)
|
19 (53)
|
3 (14)
| |
Trauma
|
15 (26)
|
7 (19)
|
8 (38)
| |
- a Independent samples t test, b Fisher exact test, c Chi-square test